1. Home
  2. KYMR vs LOT Comparison

KYMR vs LOT Comparison

Compare KYMR & LOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • LOT
  • Stock Information
  • Founded
  • KYMR 2015
  • LOT 1948
  • Country
  • KYMR United States
  • LOT China
  • Employees
  • KYMR N/A
  • LOT N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • LOT
  • Sector
  • KYMR Health Care
  • LOT
  • Exchange
  • KYMR Nasdaq
  • LOT NYSE
  • Market Cap
  • KYMR 2.6B
  • LOT 2.5B
  • IPO Year
  • KYMR 2020
  • LOT N/A
  • Fundamental
  • Price
  • KYMR $40.61
  • LOT $3.47
  • Analyst Decision
  • KYMR Buy
  • LOT
  • Analyst Count
  • KYMR 15
  • LOT 0
  • Target Price
  • KYMR $55.60
  • LOT N/A
  • AVG Volume (30 Days)
  • KYMR 532.1K
  • LOT 146.2K
  • Earning Date
  • KYMR 02-20-2025
  • LOT 11-21-2024
  • Dividend Yield
  • KYMR N/A
  • LOT N/A
  • EPS Growth
  • KYMR N/A
  • LOT N/A
  • EPS
  • KYMR N/A
  • LOT N/A
  • Revenue
  • KYMR $87,563,000.00
  • LOT $1,013,890,000.00
  • Revenue This Year
  • KYMR N/A
  • LOT $41.67
  • Revenue Next Year
  • KYMR $33.16
  • LOT $65.29
  • P/E Ratio
  • KYMR N/A
  • LOT N/A
  • Revenue Growth
  • KYMR 86.92
  • LOT 213.08
  • 52 Week Low
  • KYMR $26.92
  • LOT $3.05
  • 52 Week High
  • KYMR $53.27
  • LOT $17.99
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 47.90
  • LOT 44.54
  • Support Level
  • KYMR $40.20
  • LOT $3.05
  • Resistance Level
  • KYMR $44.34
  • LOT $4.09
  • Average True Range (ATR)
  • KYMR 2.58
  • LOT 0.36
  • MACD
  • KYMR 0.29
  • LOT -0.02
  • Stochastic Oscillator
  • KYMR 57.47
  • LOT 31.11

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

About LOT LOTUS TECHNOLOGY INC

Lotus Technology Inc is a battery electric vehicle (BEV) maker that designs, develops, and sells BEV lifestyle vehicles under the Lotus brand. The Group is also a distributor that sells luxury sports cars under the Lotus brand. It also provides other sales and ancillary services to customers.

Share on Social Networks: